Suppr超能文献

National guidelines for diagnosis and treatment of lung cancer 2022 in China (English version).

作者信息

Health Commission Of The People's Republic Of China National

出版信息

Chin J Cancer Res. 2022 Jun 30;34(3):176-206. doi: 10.21147/j.issn.1000-9604.2022.03.03.

Abstract
摘要

相似文献

1
National guidelines for diagnosis and treatment of lung cancer 2022 in China (English version).
Chin J Cancer Res. 2022 Jun 30;34(3):176-206. doi: 10.21147/j.issn.1000-9604.2022.03.03.
2
National Health Commission guidelines for diagnosis and treatment of colorectal cancer 2023 in China (English version).
Chin J Cancer Res. 2023 Jun 30;35(3):197-232. doi: 10.21147/j.issn.1000-9604.2023.03.01.
3
Comments on .
Chin J Cancer Res. 2023 Oct 30;35(5):431-432. doi: 10.21147/j.issn.1000-9604.2023.05.01.
4
National guidelines for diagnosis and treatment of colorectal cancer 2020 in China (English version).
Chin J Cancer Res. 2020 Aug;32(4):415-445. doi: 10.21147/j.issn.1000-9604.2020.04.01.
5
National guidelines for diagnosis and treatment of thyroid cancer 2022 in China (English version).
Chin J Cancer Res. 2022 Jun 30;34(3):131-150. doi: 10.21147/j.issn.1000-9604.2022.03.01.
6
National guidelines for diagnosis and treatment of gastric cancer 2022 in China (English version).
Chin J Cancer Res. 2022 Jun 30;34(3):207-237. doi: 10.21147/j.issn.1000-9604.2022.03.04.
7
National guidelines for diagnosis and treatment of cervical cancer 2022 in China (English version).
Chin J Cancer Res. 2022 Jun 30;34(3):256-269. doi: 10.21147/j.issn.1000-9604.2022.03.06.
8
National guidelines for diagnosis and treatment of breast cancer 2022 in China (English version).
Chin J Cancer Res. 2022 Jun 30;34(3):151-175. doi: 10.21147/j.issn.1000-9604.2022.03.02.
9
National guidelines for diagnosis and treatment of prostate cancer 2022 in China (English version).
Chin J Cancer Res. 2022 Jun 30;34(3):270-288. doi: 10.21147/j.issn.1000-9604.2022.03.07.
10
National guidelines for diagnosis and treatment of pancreatic cancer 2022 in China (English version).
Chin J Cancer Res. 2022 Jun 30;34(3):238-255. doi: 10.21147/j.issn.1000-9604.2022.03.05.

引用本文的文献

1
Fructose-diphosphate aldolase C as a novel diagnostic biomarker for early-stage non-small cell lung cancer: a low-abundance proteomics study.
Transl Lung Cancer Res. 2025 Jun 30;14(6):2239-2256. doi: 10.21037/tlcr-2025-530. Epub 2025 Jun 18.
2
3
Cost-effectiveness analysis of Toripalimab regimen for extensive-stage small-cell lung cancer in China and America.
Front Immunol. 2025 May 16;16:1556100. doi: 10.3389/fimmu.2025.1556100. eCollection 2025.
4
Percutaneous coronary intervention-lobectomy for Lung Cancer hybrid surgery: an initial case series.
Cardiooncology. 2025 Feb 21;11(1):20. doi: 10.1186/s40959-025-00317-6.
6
Multi-region infectious disease prediction modeling based on spatio-temporal graph neural network and the dynamic model.
PLoS Comput Biol. 2025 Jan 9;21(1):e1012738. doi: 10.1371/journal.pcbi.1012738. eCollection 2025 Jan.
7
Risk factors for postoperative pulmonary infections in non-small cell lung cancer: a regression-based nomogram prediction model.
Am J Cancer Res. 2024 Nov 15;14(11):5365-5377. doi: 10.62347/BIBD8425. eCollection 2024.
10
Efficacy of argon-helium cryoablation combined with chemotherapy in the treatment of advanced NSCLC.
Pak J Med Sci. 2024 Oct;40(9):2017-2021. doi: 10.12669/pjms.40.9.9882.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验